CDEK by Data4ThePeople
Sign in Sign up
← All drugs Report issue

yh003

mAbexperimental

Clinical trial activity

5 trials · 1 clinical orgs · 0 marketing orgs

Phase 1
3
Phase 2
3
Phase 3
0
Phase 4
0

Earliest trial started Jul 31, 2020 (NCT04481009)

Timeline

2020s

  1. Jan 1, 2020

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2021

    Earliest Phase 2 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Multi-specific
No

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05420324Phase 2Jun 13, 2022Eucure (Beijing) Biopharma Co., Ltd
NCT05176509Phase 1Apr 5, 2022Eucure (Beijing) Biopharma Co., Ltd
NCT05031494Phase 2Dec 31, 2021Eucure (Beijing) Biopharma Co., Ltd
NCT05017623Phase 1Aug 26, 2021Eucure (Beijing) Biopharma Co., Ltd
NCT04481009Phase 1/Phase 2 (Phase 2)Jul 31, 2020Eucure (Beijing) Biopharma Co., Ltd
Showing 5 of 5 trials
Page 1 / 1

Organizations

Research & Development (1)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Eucure (Beijing) Biopharma Co., LtdFor profit5522020
1 organizations
Page 1 / 1